ישראל - עברית - Ministry of Health

dexcel ltd, israel - mitomycin c (crystalline) - אבקה להכנת תמיסה לזריקה - mitomycin c (crystalline) 10 mg/vial - mitomycin - mitomycin - remission of subjective and objective symptoms assocciated with the following diseases: - chronic lymphocytic leukemia, - chronic myelocytic leukemia, - gastric cancer, - colorectal cancer, - lung cancer, - pancreatic cancer, - liver cancer, - cervix cancer, - cancer of the endometrium, - breast cancer, - head and neck tumor, - bladder tumor.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - mitomycin c ( crystalline ) - אבקה להכנת תמיסה לזריקה - mitomycin c ( crystalline ) 2 mg/vial - mitomycin - mitomycin - remission of subjective and objective symptoms assocciated with the following diseases: chronic lymphocytic leukemia, chronic myelocytic leukemia, gastric cancer, colorectal cancer, lung cancer, pancreatic cancer, liver cancer, cervix cancer, cancer of the endometrium, breast cancer, head and neck tumor and bladder tumor.

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - neomycin sulfate - טבליה - neomycin sulfate 500 mg - neomycin - neomycin - diarrhea due to enteropathogenic escherichia coli. supression of intestinal bacteria prior to intestinal surgery or as an adjunct in hepatic coma.

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - mitomycin - mitomycin 40 mg/vial - mitomycin

ישראל - עברית - Ministry of Health

biovac ltd., israel - neomycin sulfate - אבקה להכנת תמיסה - neomycin sulfate 100 %

ישראל - עברית - Ministry of Health

abic veterinary products ltd - neomycin sulfate - אבקה להכנת תמיסה - neomycin sulfate 100 %

ישראל - עברית - Ministry of Health

teva israel ltd - hydrocortisone; neomycin as sulfate - משחה - neomycin as sulfate 0.5 %; hydrocortisone 2.5 % - hydrocortisone and antibiotics - hydrocortisone and antibiotics - allergic dermatoses and other corticosteroid responsive inflammatory skin diseases including atopic dermatitis, contact dermatitis, seborrheic dermatitis, anogenital pruritus, infantile eczema and external otitis.

ישראל - עברית - Ministry of Health

abic veterinary products ltd - neomycin sulfate - אבקה להכנת תמיסה - neomycin sulfate 100 %

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 500 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 750 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n